M1003 Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
Short descriptor: Tb scr 12 mo pri fst bio dz
Look up M1003 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
M1003 is the HCPCS Level II code for Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.
Classification & CMS Attributes
- Section
- M: Medical Services
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Not separately priced by Part B (indicator 00)
- Type of Service
- Medical care
- Effective Date
- 2023-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference M1003 with the canonical source and edition:
M1003 — Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M1003
Canonical URL: https://icd10codingpro.com/hcpcs-codes/M1003